Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP800613.RASwF7bhEyFpWBzqNNfI7p96oqLKPEVALsDxYh9-Wsb4I130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP800613.RASwF7bhEyFpWBzqNNfI7p96oqLKPEVALsDxYh9-Wsb4I130_assertion type Assertion NP800613.RASwF7bhEyFpWBzqNNfI7p96oqLKPEVALsDxYh9-Wsb4I130_head.
- NP800613.RASwF7bhEyFpWBzqNNfI7p96oqLKPEVALsDxYh9-Wsb4I130_assertion description "[The effects of prolactin (PRL) during the pathogenesis of breast cancer are mediated in part though Stat5 activity enhanced by its interaction with its transcriptional inducer, the prolyl isomerase cyclophilin B (CypB).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP800613.RASwF7bhEyFpWBzqNNfI7p96oqLKPEVALsDxYh9-Wsb4I130_provenance.
- NP800613.RASwF7bhEyFpWBzqNNfI7p96oqLKPEVALsDxYh9-Wsb4I130_assertion evidence source_evidence_literature NP800613.RASwF7bhEyFpWBzqNNfI7p96oqLKPEVALsDxYh9-Wsb4I130_provenance.
- NP800613.RASwF7bhEyFpWBzqNNfI7p96oqLKPEVALsDxYh9-Wsb4I130_assertion SIO_000772 20237142 NP800613.RASwF7bhEyFpWBzqNNfI7p96oqLKPEVALsDxYh9-Wsb4I130_provenance.
- NP800613.RASwF7bhEyFpWBzqNNfI7p96oqLKPEVALsDxYh9-Wsb4I130_assertion wasDerivedFrom befree-2016 NP800613.RASwF7bhEyFpWBzqNNfI7p96oqLKPEVALsDxYh9-Wsb4I130_provenance.
- NP800613.RASwF7bhEyFpWBzqNNfI7p96oqLKPEVALsDxYh9-Wsb4I130_assertion wasGeneratedBy ECO_0000203 NP800613.RASwF7bhEyFpWBzqNNfI7p96oqLKPEVALsDxYh9-Wsb4I130_provenance.